Download PDF

Other users also viewed these articles

Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28:
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: